| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| halothane | Inhalation | 0.01% | |
| isoflurane | Inhalation | N/A | |
| ketamine | Injection | 50 mg (as hydrochloride)/mL in 10-mL vial | |
| nitrous oxide | Inhalation | N/A | |
| oxygen | Inhalation (medicine gas) | N/A | |
| propofol | Injection | 10 mg/mL | |
| sevoflurane | Inhalation | N/A | |
| thiopental | Injection | 1 g (as sodium) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bupivacaine | Injection | 0.25% (hydrochloride) in vial | |
| bupivacaine | Injection | 0.5% (hydrochloride) in vial | |
| bupivacaine | Injection for spinal anaesthesia | 0.5% (hydrochloride) in 20-ml ampoule to be mixed with 7.5% glucose solution | |
| ephedrine | Injection | 30 mg (hydrochloride)/ml in 1-ml ampoule | |
| lidocaine | Injection | 1% (hydrochloride) in vial | |
| lidocaine | Injection | 75 mg/ ml 7.5% | |
| lidocaine | Injection for spinal anaesthesia | 5% (hydrochloride) in 2-ml ampoule to be mixed with 7.5% glucose solution | |
| lidocaine | Solution for injection | 0.5% 5mg/ml | |
| lidocaine + epinephrine (adrenaline) | Dental cartridge | 2% (hydrochloride) + epinephrine 1:80 000 | |
| lidocaine + epinephrine (adrenaline) | Dental cartridge | 2% 1:200.000 | |
| lidocaine + epinephrine (adrenaline) | Injection | 1% (hydrochloride or sulfate) + epinephrine 1:200 000 in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atropine | Injection | 0.6 mg/ml | |
| chloral hydrate | mixture | 500 mg/ml | |
| diazepam | Injection | 5 mg/mL | |
| diazepam | Tablet | 2 mg | |
| diazepam | Tablet | 5 mg | |
| midazolam | Injection | 1 mg/ml | |
| promethazine | Injection | 25mg (hydrochloride)/ml | |
| promethazine | Oral solution | 1mg/mL | |
| promethazine | Tablet | 10 mg | |
| promethazine | Tablet | 25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atracurium | Injection | 10 mg/mL (besylate) | |
| dantrolene | Injection | 20 mg (sodium) | |
| mivacuronium | Injection | 10-mg vial | |
| neostigmine | Injection | 2.5 mg/ml | |
| neostigmine | Injection | 500 mcg in 1-mL ampoule | |
| orfenadrine | Tablet | 100mg (citrate) | |
| pancuronium | Injection | 2 mg/ml | |
| pyridostigmine | Tablet | 60 mg | |
| suxamethonium | Injection | 50 mg (chloride)/ml in 2-ml ampoule | |
| suxamethonium | Powder for injection | (chloride), in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylsalicylic acid | Tablet | 300 mg | |
| acetylsalicylic acid | Tablet | 81mg | |
| diclofenac | Injection | 25 mg (sodium)/mL | |
| diclofenac (sodium) | Tablet | 50mg | |
| ibuprofen | Syrup | 100 mg/ 5ml | |
| ibuprofen | Tablet | 200 mg | |
| ibuprofen | Tablet | 400 mg | |
| indomethacin | Suppository | 100 mg | |
| indomethacin | Tablet | 25 mg | |
| naproxen | Tablet | 250 mg | |
| naproxen | Tablet | 500 mg | |
| paracetamol | Oral liquid | 120 mg/5 mL | |
| paracetamol | Oral liquid | 125 mg/5 ml | |
| paracetamol | Oral liquid | 250 mg/ 5ml | |
| paracetamol | Suppository | 100 mg | |
| paracetamol | Suppository | 125 mg | |
| paracetamol | Suppository | 250 mg | |
| paracetamol | Suppository | 500 mg | |
| paracetamol | Suppository | 60 mg | |
| paracetamol | Tablet | 500 mg | |
| paracetamol | Tablet (dispersible) | 120 mg | |
| paracetamol | Tablet (dispersible) | 500 mg | |
| piroxicam | Capsule | 20 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetaminophen/codeine | Tablet | 300 mg + 30mg | |
| codeine | Tablet | 30 mg | |
| fentanyl | Injection | 50 mcg (citrate)/mL | |
| hydromorphone | Tablet | 4 mg | |
| hydromorphone | Tablet (controlled release) | 3 mg | |
| methadone | Powder | 1 mg/ml | |
| morphine | Injection | 10 mg (sulfate or hydrochloride) in 1-ml ampoule | |
| morphine | Oral liquid | 10 mg (hydrochloride or sulfate)/5 ml | |
| morphine | Tablet | 10 mg - 200 mg (morphine sulfate) | |
| morphine | Tablet (controlled release) | 30 mg | |
| oxycodone | Tablet (controlled release) | 20 mg | |
| oxycodone | Tablet (immediate release) | 10 mg | |
| pethidine | Injection | 100 mg/mL | |
| pethidine | Injection | 50 mg/ml | |
| pethidine | Tablet | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| allopurinol | Tablet | 100 mg | |
| allopurinol | Tablet | 300 mg | |
| azathioprine | Tablet | 50 mg | |
| chloroquine | Tablet | 200 mg | |
| chloroquine | Tablet | 250mg (150mg base) as phosphate | |
| methotrexate | Tablet | 2.5 mg (as sodium salt) | |
| penicillamine | Capsule | 125 mg. | |
| penicillamine | Capsule | 250 mg | |
| penicillamine | Tablet | 125 mg | |
| penicillamine | Tablet | 250 mg | |
| sulfasalazine | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chlorpheniramine | Injection | 10 mg/mL (IM,IV) | |
| chlorpheniramine | Syrup | 2 mg/ 5ml x 100ml | |
| chlorpheniramine | Tablet | 4 mg | |
| dexamethasone | Injection | 4 mg (sodium phosphate) in 1-mL vial | |
| dobutamine | Injection | 12.5 mg/mL | |
| dobutamine | Tablet | 4 mg | |
| dobutamine | Tablet | 500 mcg | |
| dopamine | Injection | 40 mg/mL (hydrochloride) in 5-mL vial | |
| epinephrine (adrenaline) | Injection | 1 mg (hydrochloride)/mL | |
| hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial | |
| ketotifen | Oral liquid | 1mg/5ml | |
| ketotifen | Tablet | 1 mg | |
| loratadine | Tablet | 10 mg | |
| methylprednisolone | Injection | 500 mg (sodium succinate) | |
| prednisolone | Tablet | 25 mg | |
| prednisolone | Tablet | 5 mg | |
| promethazine | Injection | 25mg (hydrochloride)/ml | |
| promethazine | Tablet | 25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| charcoal, activated | Powder | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylcysteine | Injection | 200 mg/ml in 10-ml ampoule | |
| atropine | Injection | 1 mg (sulfate) in 1-ml ampoule | |
| calcium gluconate | Injection | 100 mg/mL in 10-mL ampoule | |
| deferoxamine | Powder for injection | 500 mg (mesilate) in vial | |
| flumazenil | Injection | 100mcg/ml | |
| methylthioninium chloride (methylene blue) | Injection | 10 mg/ml in 10-ml ampoule | |
| naloxone | Injection | 400 mcg (hydrochloride) in 1-mL ampoule | |
| penicillamine | Capsule | 125 mg. | |
| penicillamine | Capsule | 250 mg | |
| penicillamine | Tablet | 125 mg | |
| penicillamine | Tablet | 250 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carbamazepine | Tablet | 100 mg | |
| carbamazepine | Tablet | 200 mg | |
| clonazepam | Tablet | 1 mg | |
| diazepam | Injection | 5 mg/mL | |
| ethosuximide | Capsule | 250 mg | |
| ethosuximide | Oral liquid | 250 mg/5 ml | |
| lamotrigine | Tablet | 25 mg | |
| phenobarbital | elixir | 50 mg/ 5ml | |
| phenobarbital | Injection | 200 mg (sodium)/mL | |
| phenobarbital | Tablet | 30 mg | |
| phenobarbital | Tablet | 60 mg | |
| phenytoin | Injection | 50 mg/mL in 5-mL vial (sodium salt) | |
| phenytoin | Oral liquid | 125 mg/5 mL | |
| phenytoin | Solid oral dosage form | 100 mg (sodium salt) | |
| valproic acid (sodium valproate) | Tablet | 200 mg | |
| valproic acid (sodium valproate) | Tablet (enteric-coated) | 200 mg (sodium valproate) | |
| valproic acid (sodium valproate) | Tablet (enteric-coated) | 500 mg (sodium valproate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| albendazole | Tablet (chewable) | 400 mg | |
| niclosamide | Tablet (chewable) | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amoxicillin | Suspension | 125 mg/ 5 ml | |
| amoxicillin | Tablet | 250 mg | |
| amoxicillin | Tablet | 500 mg | |
| amoxicillin + clavulanic acid | Oral liquid | 125 mg amoxicillin + 31.25 mg clavulanic acid/5 ml | |
| amoxicillin + clavulanic acid | Tablet | 500 mg (as trihydrate) + 125 mg (as potassium salt) | |
| ampicillin | Powder for injection | 1 g (as sodium salt) in vial | |
| ampicillin | Powder for injection | 500 mg (as sodium salt) in vial | |
| benzathine benzylpenicillin | Powder for injection | 1.44 g benzylpenicillin (= 2.4 million IU) in 5-ml vial | |
| benzylpenicillin | Powder for injection | 1 million IU | |
| benzylpenicillin | Powder for injection | 5 million IU | |
| cefalexin | Suspension | 125 mg/ 5ml | |
| cefalexin | Tablet | 250 mg | |
| cefalexin | Tablet | 500 mg | |
| cefotaxime | Injection | 1 g | |
| ceftazidime | Injection | 250 mg | |
| ceftriaxone | Powder for injection | 250 mg (as sodium salt) in vial | |
| cefuroxime | Injection | 750 mg | |
| cefuroxime | Suspension | 125 mg/5 ml | |
| cloxacillin | Capsule | 500 mg (as sodium salt) | |
| cloxacillin | Injection | 500 mg | |
| cloxacillin | Powder for oral liquid | 125 mg (as sodium salt)/5 mL | |
| imipenem + cilastatin | Powder for injection | 250 mg (as monohydrate) + 250 mg (as sodium salt) in vial | |
| imipenem + cilastatin | Powder for injection | 500 mg (as monohydrate) + 500 mg (as sodium salt) in vial | |
| phenoxymethylpenicillin | Suspension | 250 mg/5mL | |
| phenoxymethylpenicillin | Tablet | 250 mg (as potassium salt) | |
| procaine benzylpenicillin | Powder for injection | 1 g (=1 million IU) in vial | |
| procaine benzylpenicillin | Powder for injection | 3 g (=3 million IU) in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| rifampicin | Capsule | 150 mg | |
| rifampicin | Capsule | 300 mg | |
| rifampicin | Solid oral dosage form | 300 mg | |
| rifampicin | Tablet | 150 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ethambutol | Tablet | 400mg | |
| isoniazid | Tablet | 300 mg | |
| pyrazinamide | Tablet | 400 mg | |
| rifampicin | Capsule | 300 mg | |
| rifampicin | Tablet | 150 mg | |
| streptomycin | Powder for injection | 1 g |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amikacin | Injection | 250 mg/mL in 2-mL vial | |
| azithromycin | Capsule | 250 mg (anhydrous) | |
| azithromycin | Capsule | 500 mg (anhydrous) | |
| azithromycin | Suspension | 200 mg/5 ml | |
| chloramphenicol | Eye ointment | 1% | |
| chloramphenicol | Oily suspension for injection | 0.5 g (as sodium succinate)/ml in 2-ml ampoule | |
| chloramphenicol | Powder for injection | 1 g (sodium succinate) in vial | |
| chloramphenicol | Solution (eye drops) | 0.5% | |
| ciprofloxacin | Injection | 400 mg | |
| ciprofloxacin | Tablet | 250 mg (as hydrochloride) | |
| ciprofloxacin | Tablet | 500 mg | |
| doxycycline | Capsule | 100 mg (as hydrochloride or hyclate) | |
| erythromycin | Powder for oral liquid | 125 mg/5 mL (as stearate or estolate or ethyl succinate) | |
| erythromycin | Tablet | 250 mg (stearate) | |
| gentamicin | Injection | 10 mg (sulfate)/mL in 2-mL vial | |
| gentamicin | Injection | 40 mg (sulfate)/ml in 2-mL vial | |
| metronidazole | Injection | 5 mg/mL | |
| metronidazole | Suppository | 500 mg | |
| metronidazole | Suspension | 200 mg/ 5 ml | |
| metronidazole | Tablet | 250 mg | |
| nitrofurantoin | Tablet | 100 mg | |
| spectinomycin | Powder for injection | 2 g (as hydrochloride) in vial | |
| sulfamethoxazole + trimethoprim | Injection | 80 mg + 16 mg/mL in 10-mL ampoule | |
| sulfamethoxazole + trimethoprim | Injection | 80 mg + 16 mg/mL in 5-mL ampoule | |
| sulfamethoxazole + trimethoprim | Oral liquid | 200 mg + 40 mg/5 mL | |
| sulfamethoxazole + trimethoprim | Tablet | 400 mg + 80 mg | |
| sulfamethoxazole + trimethoprim | Tablet | 800 mg + 160 mg | |
| vancomycin | Powder for injection | 250 mg (as hydrochloride) in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amphotericin B | Powder for injection | 50 mg in vial | |
| clotrimazole | Cream | 1% | |
| clotrimazole | Tablet | 500 mg | |
| fluconazole | Capsule | 150 mg | |
| fluconazole | Capsule | 200 mg | |
| fluconazole | Injection | 2 mg/mL in vial | |
| fluconazole | Suspension | 50 mg/ 5ml | |
| flucytosine | Capsule | 250 mg | |
| flucytosine | Infusion | 10 mg/ ml | |
| griseofulvin | Suspension | 125 mg/ 5 ml | |
| griseofulvin | Tablet | 500mg | |
| ketoconazole | Tablet | 200 mg | |
| miconazole | Cream | 1 % | |
| nystatin | Lozenge | 100 000 IU | |
| nystatin | Oral liquid | 100 000 IU/ml | |
| nystatin | Oral liquid | 100 000 IU/ml | |
| nystatin | Pessary | 100 000 IU | |
| nystatin | Tablet | 100 000 IU | |
| nystatin | Tablet | 500 000 IU |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aciclovir | Eye ointment | 3% | |
| aciclovir | Ointment | 5% | |
| aciclovir | Powder for injection | 250 mg (as sodium salt) in vial | |
| aciclovir | Tablet | 400 mg | |
| oseltamivir | Capsule | 75 mg | |
| oseltamivir | Oral liquid | 60 mg/ 5 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| abacavir (ABC) | Oral liquid | 100 mg (as sulfate)/5 ml | |
| didanosine (ddI) | Powder for solution | 2 g | |
| lamivudine (3TC) | Oral liquid | 50 mg/5 ml | |
| lamivudine (3TC) | Tablet | 150 mg | |
| lamivudine + zidovudine | Tablet | 150 mg + 300 mg | |
| stavudine (d4T) | Capsule | 30 mg | |
| stavudine (d4T) | Powder for oral liquid | 5 mg/5 ml | |
| zidovudine (ZDV or AZT) | Oral liquid | 50 mg/5 mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| efavirenz (EFV or EFZ) | Capsule | 600 mg | |
| efavirenz (EFV or EFZ) | Oral liquid | 150 mg/5 ml | |
| nevirapine (NVP) | Oral liquid | 50 mg/5 ml | |
| nevirapine (NVP) | Tablet | 200 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| indinavir (IDV) | Capsule | 400mg | |
| lopinavir + ritonavir (LPV/r) | Suspension | 20 mg + 80mg/ 160 mls | |
| ritonavir | Capsule | 100 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| metronidazole | Injection | 5 mg/ml | |
| metronidazole | Oral liquid | 200 mg (as benzoate)/5 mL | |
| metronidazole | Tablet | 200 mg to 500 mg | |
| tinidazole | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| PENTAVALENT ANTIMONY COMPOUNDS | Injection | 100 mg/ml | |
| PENTAVALENT ANTIMONY COMPOUNDS | Injection | 85 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chloroquine | Injection | 40 mg/ml | |
| chloroquine | Oral liquid | 50 mg (as phosphate or sulfate)/5 ml | |
| chloroquine | Tablet | 100 mg (as phosphate or sulfate) | |
| chloroquine | Tablet | 150mg (phosphate) | |
| doxycycline | Capsule | 100 mg (as hydrochloride or hyclate) | |
| doxycycline | Tablet | 100mg | |
| primaquine | Tablet | 15 mg (as diphosphate) | |
| primaquine | Tablet | 7.5 mg (as diphosphate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ergotamine | Tablet | 1 mg | |
| paracetamol | Tablet | 500 mg | |
| sumatriptan | Tablet | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| propranolol | Tablet | 20 mg (hydrochloride) | |
| propranolol | Tablet | 40 mg (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| azathioprine | Powder for injection | 100 mg (as sodium salt) in vial | |
| azathioprine | Tablet | 50 mg | |
| ciclosporin | Capsule | 25 mg | |
| ciclosporin | Concentrate for injection | 50 mg/ml in 1-ml ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cyclophosphamide | Powder for injection | 500 mg in vial | |
| cyclophosphamide | Tablet | 25 mg | |
| fluorouracil | Injection | 50 mg/ml in 5-ml ampoule | |
| methotrexate | Solution for injection | 25 mg/ ml | |
| methotrexate | Tablet | 2.5 mg (as sodium salt) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| octreotide | Injection | 0.2 mg/ml (1ml) | |
| octreotide | Injection | 0.5 mg/mL | |
| octreotide | Solution for injection | 0.1 mg/mL - 1mL | |
| prednisolone | Tablet | 25 mg | |
| prednisolone | Tablet | 5 mg | |
| tamoxifen | Tablet | 10 mg (as citrate) | |
| tamoxifen | Tablet | 20 mg (as citrate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| benzhexol | Tablet | 2 mg | |
| benzhexol | Tablet | 5 mg | |
| biperiden | Injection | 5 mg (lactate) in 1-ml ampoule | |
| biperiden | Tablet | 2 mg (hydrochloride) | |
| biperiden | Tablet | 4 mg (hydrochloride) | |
| levodopa + carbidopa | Capsule | 250mg + 25mg | |
| levodopa + carbidopa | Tablet | 100 mg + 10 mg | |
| procyclidine | Injection | 5 mg/mL in ampoule | |
| procyclidine | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ferroso gluconato | Tablet | 300 mg (35 mg iron) | |
| ferrous fumarate | Oral solution | 25 mg iron/mL | |
| ferrous fumarate | Tablet | 210 mg (68 mg iron) | |
| ferrous fumarate + folic acid | Tablet | 322 mg (105 mg iron), folic acid 350 micrograms | |
| ferrous salt | Tablet | equivalent to 60 mg iron | |
| ferrous salt | Tablet | equivalent to 65 mg iron | |
| ferrous salt + folic acid | Tablet | 160 mg (50 mg iron), folic acid 400 micrograms | |
| ferrous salt + folic acid | Tablet | 325 mg (105 mg iron), folic acid 350 micrograms | |
| folic acid | Tablet | 1 mg | |
| folic acid | Tablet | 5 mg | |
| hydroxocobalamin | Injection | 1 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| heparin sodium | Injection | 1000 IU/mL in 1-mL ampoule | |
| heparin sodium | Injection | 25000 IU (unfractionated) | |
| heparin sodium | Injection | 5000 U/ml | |
| phytomenadione | Injection | 10 mg/mL in 5-mL ampoule | |
| phytomenadione | Tablet | 10 mg | |
| protamine sulfate | Injection | 10 mg/mL in 5-mL ampoule | |
| warfarin | Tablet | 1 mg (sodium salt) | |
| warfarin | Tablet | 2 mg (sodium salt) | |
| warfarin | Tablet | 5 mg (sodium salt) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dextran 70 | Injectable solution | 6% in 5% dextrose | |
| plasma protein fraction | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| factor IX complex (coagulation factors, II, VII, IX, X) concentrate | Powder for infusion | 500–1500 units | |
| factor VII | Powder for infusion | 250– 1500 units |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atenolol | Injection | 0.5 mg/10 mL | |
| atenolol | Tablet | 100 mg | |
| atenolol | Tablet | 50 mg | |
| diltiazem | Tablet | 60 mg | |
| glyceryl trinitrate | Injection | 50 mg/ 10ml | |
| glyceryl trinitrate | Tablet (sublingual) | 500 mcg | |
| isosorbide dinitrate | Tablet (sublingual) | 10 mg | |
| verapamil | Injection | 75 mg/ml | |
| verapamil | Tablet | 120 mg (hydrochloride) | |
| verapamil | Tablet | 80 mg (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atenolol | Tablet | 100 mg | |
| atenolol | Tablet | 50 mg | |
| digoxin | Injection | 0.25 mg/ml | |
| digoxin | Oral liquid | 50 micrograms/mL | |
| digoxin | Tablet | 0.125 mg | |
| digoxin | Tablet | 0.25 mg | |
| Disopyramide Phosphate | Tablet | 100 mg | |
| epinephrine (adrenaline) | Injection | 100 mcg/mL | |
| lidocaine | Solution for injection | 100 mg/ 5 ml | |
| quinidine | Tablet | 200 mg | |
| verapamil | Tablet | 40 mg (hydrochloride) | |
| verapamil | Tablet | 80 mg (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amlodipine | Tablet | 5 mg | |
| atenolol | Tablet | 100 mg | |
| atenolol | Tablet | 50 mg | |
| captopril | Tablet | 12.5 mg | |
| captopril | Tablet | 25 mg | |
| enalapril | Tablet | 20 mg | |
| enalapril | Tablet | 5 mg | |
| furosemide | Injection | 10 mg/mL in 2-mL ampoule | |
| hydralazine | Powder for injection | 20 mg (hydrochloride) in ampoule | |
| hydralazine | Tablet | 25 mg (hydrochloride) | |
| hydrochlorothiazide | Tablet (scored) | 25 mg | |
| hydrochlorothiazide | Tablet (scored) | 50mg | |
| labetalol | Injection | 5mg/ml | |
| losartan | Tablet | 25 mg | |
| losartan | Tablet | 50 mg | |
| methyldopa | Tablet | 250 mg | |
| metoprolol | Injection | 1 mg/ml | |
| metoprolol | Tablet | 100 mg | |
| metoprolol | Tablet | 50 mg | |
| minoxidil | Tablet | 5 mg | |
| nifedipine | Tablet | 10 mg | |
| nimodipine | Capsule | 30 mg | |
| prazosin | Tablet | 1mg | |
| propranolol | Tablet | 40mg | |
| sildenafil | Tablet | 25 mg | |
| sodium nitroprusside | Injection | 10 mg | |
| sodium nitroprusside | Powder for infusion | 50 mg in ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| digoxin | Capsule | 100 mcg | |
| digoxin | Capsule | 200 mg | |
| digoxin | Injection | 100 mcg/ ml | |
| digoxin | Injection | 250 micrograms/mL in 2-mL ampoule | |
| digoxin | Oral liquid | 50 micrograms/mL | |
| digoxin | Tablet | 0.125 mg | |
| digoxin | Tablet | 250 mcg | |
| digoxin | Tablet | 62.5 micrograms | |
| dopamine | Injection | 40 mg/mL (hydrochloride) in 5-mL vial | |
| enalapril | Tablet | 2.5 mg | |
| hydrochlorothiazide | Tablet (scored) | 25 mg | |
| milrinone | Injection | 1 mg/mL | |
| prostaglandin E | Injection | 500 mcg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylsalicylic acid | Tablet | 81mg | |
| acetylsalicylic acid | Tablet (dispersible) | 75 mg | |
| dipyridamole | Tablet | 25 mg | |
| streptokinase | Powder for injection | 1.5 million IU in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| gemfibrozil | Tablet | 300 mg | |
| gemfibrozil | Tablet | 600mg | |
| niacin | Tablet | 600 mg | |
| simvastatin | Tablet | 10 mg | |
| simvastatin | Tablet | 20 mg | |
| tissue plasminogen activator | N/A | 100 mg | |
| tissue plasminogen activator | N/A | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clotrimazole | Vaginal cream | 1% | |
| ketoconazole | Tablet | 200 mg | |
| miconazole | Cream | 2% (nitrate) | |
| miconazole | Ointment | 2% (nitrate) | |
| nystatin | Ointment | 10% | |
| salicylic acid + benzoic acid + precipitated sulfur (Whitfield´s ointment with sulfur) | Ointment | 6% + 3% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acriflavine BPC | Solution | 0.1% | |
| bacitracin + neomycin | Cream | 500 IU + 5mg (as sulfate)/g | |
| gentian violet | Solution | 0.5% | |
| potassium permanganate | Aqueous solution | 1:10 000 | |
| silver sulfadiazine | Cream | 1% 500 gm |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| betamethasone | Cream | 0.1% (as valerate) | |
| betamethasone | Ointment | 0.1% (as valerate) | |
| calamine | Lotion | 15% | |
| calamine | Lotion | 8% | |
| hydrocortisone | Cream | 1% (acetate) | |
| hydrocortisone | Ointment | 1% (acetate) | |
| Xyloproct | N/A | Aluminium acetate 3.5%,, hydrocortisone acetate 0.275%, lidocaine 10%, zinc oxide 18% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| zinc oxide | Cream | 15 g |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| benzoyl peroxide | Cream | 5% | |
| benzoyl peroxide | Lotion | 5% | |
| podophyllum resin | Solution | 10% to 25% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| benzyl benzoate | Lotion | 25% | |
| lindane | Cream | 1% | |
| lindane | Lotion | 1 % | |
| lindane | shampoo | 1 % | |
| permethrin | Cream | 5% | |
| permethrin | Lotion | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| barium sulfate | Aqueous suspension | N/A | |
| sodium diatrizoato + meglumine diatrizoato | Injection | 140-420mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cetrimide | Solution | 20% | |
| chlorhexidine | Solution | 5% (digluconate) | |
| ethanol | Solution | 70% (denatured) | |
| hydrogen peroxide | Solution | 3% | |
| hydrogen peroxide | Solution | 6% | |
| polyvidone iodine | Solution | 10% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chlorine base compound | Powder | (0.1% available chlorine) for solution | |
| glutaral | Solution | 2% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Bumetanide | Tablet | 1 mg | |
| furosemide | Injection | 10 mg/mL in 2-mL ampoule | |
| furosemide | Tablet | 40 mg | |
| hydrochlorothiazide | Tablet | 50 mg | |
| hydrochlorothiazide | Tablet (scored) | 25 mg | |
| mannitol | Injectable solution | 20% | |
| spironolactone | Tablet | 25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aluminum hydroxide | Oral suspension | 320 mg/5ml | |
| aluminum hydroxide | Tablet | 300 mg | |
| magnesium hydroxido | Oral suspension | 550 mg/ 10ml | |
| omeprazole | Injection | 40 mg | |
| omeprazole | Tablet | 20 mg | |
| ranitidine | Injection | 25 mg/mL (as hydrochloride) in 2-mL ampoule | |
| ranitidine | Syrup | 75 mg/ 5 ml | |
| ranitidine | Tablet | 150 mg (as hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| metoclopramide | Injection | 5 mg (hydrochloride)/mL in 2-mL ampoule | |
| metoclopramide | Tablet | 10 mg (hydrochloride) | |
| promethazine | Injection | 25mg (hydrochloride)/ml | |
| promethazine | Oral solution | 1mg/mL | |
| promethazine | Tablet | 10 mg | |
| promethazine | Tablet | 25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Anusol | Suppository | N/A | |
| LOCAL ANAESTHETIC, ASTRINGENT AND ANTI-INFLAMMATORY DRUG | Ointment | N/A | |
| Xyloproct | Suppository | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| hydrocortisone | Retention enema | 100 mg | |
| hydrocortisone | Suppository | 25 mg (acetate) | |
| sulfasalazine | Retention enema | 3 g | |
| sulfasalazine | Suppository | 500 mg | |
| sulfasalazine | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atropine | Tablet | 600 mcg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| oral rehydration salts * (for glucose-electrolyte solution) | Solution | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| loperamide | Tablet | 2 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ursodeoxycholic acid | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dexamethasone | Injection | 4 mg/mL in 1-mL ampoule (as disodium phosphate salt) | |
| hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial | |
| prednisolone | Tablet | 25 mg | |
| prednisolone | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| diethylstilbestrol | Tablet | 5 mg | |
| medroxyprogesterone acetate | Depot injection | 150 mg/mL in 1-mL vial | |
| norethisterone | Injection | 200 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| condoms | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ethinylestradiol | Tablet | 10 mcg | |
| ethinylestradiol | Tablet | 50 mcg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| medroxyprogesterone acetate | Depot injection | 150 mg/mL in 1-mL vial | |
| norethisterone | Injection | 200 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| glibenclamide | Tablet | 5 mg | |
| insulin pen 70/30 | Injection | 100 IU / 10mls | |
| intermediate-acting insulin | Injection | 100 IU/ml in 10-ml vial | |
| ISOPHANE | Injection | 100 units/ml | |
| metformin | Tablet | 500 mg | |
| metformin | Tablet | 850 mg | |
| NPH insulin (intermediate-acting insulin) | Injection | 100 IU/mL | |
| vasopressin | Injection | 20 U/ ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carbimazole | Tablet | 5 mg | |
| levothyroxine | Tablet | 100 mcg (sodium salt) | |
| potassium iodide | Tablet | 60 mg | |
| propylthiouracil | Tablet | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| tuberculin, purified protein derivative (PPD) | Injection | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| anti-D immunoglobulin (human) | Injection | 250 mcg | |
| antitetanus immunoglobulin (human) | Injection | 500 IU in vial | |
| antivenom immunoglobulin | Injection | N/A | |
| diphtheria antitoxin | Injection | 10 000 IU in vial | |
| diphtheria antitoxin | Injection | 20 000 IU in vial | |
| rabies immunoglobulin | Injection | 150 IU/mL in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| BCG vaccine | Injection | N/A | |
| diphtheria and tetanus toxoid | Injection | pediatric | |
| diphtheria, tetanus toxoid | Injection | adult | |
| diphtheria, tetanus toxoid + pertussis vaccine | Injection | N/A | |
| hepatitis B vaccine | Injection | N/A | |
| measles vaccine | Injection | N/A | |
| MMR vaccine | Injection | measles, mumps and rubella live virus | |
| poliomyelitis vaccine | Injection | N/A | |
| tetanus vaccine | Injection | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| influenza vaccine | N/A | N/A | |
| meningococcal meningitis vaccine | N/A | N/A | |
| mumps vaccine | N/A | N/A | |
| rabies vaccine | Injection | inactivated | |
| rubella vaccine | N/A | N/A | |
| typhoid vaccine | N/A | N/A | |
| yellow fever vaccine | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| neostigmine | Injection | 2.5 mg (metilsulfate) in 1-ml ampoule | |
| neostigmine | Injection | 500 mcg in 1-mL ampoule | |
| neostigmine | Tablet | 15 mg (bromide) | |
| pyridostigmine | Injection | 1 mg in 1-mL ampoule | |
| pyridostigmine | Tablet | 60 mg (bromide) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chloramphenicol | Ointment | 1% | |
| chloramphenicol | Solution (eye drops) | 0.5% | |
| ciprofloxacin | ear drops | 0.2% | |
| gentamicin | Eye ointment | 0.3% | |
| tetracycline | Eye ointment | 1 % |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| hydrocortisone | Ointment | 1% | |
| prednisolone | Solution (eye drops) | 0.5% (sodium phosphate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| tetracaine | Solution (eye drops) | 0.5% (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetazolamide | Tablet | 250 mg | |
| betaxolol | Solution (eye drops) | 0.5% | |
| pilocarpine | Solution (eye drops) | 2% (hydrochloride or nitrate) | |
| pilocarpine | Solution (eye drops) | 4% (hydrochloride or nitrate) | |
| timolol | Solution (eye drops) | 0.25% (maleate) | |
| timolol | Solution (eye drops) | 0.5% (maleate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Acyclovir | eye drops | 3 % | |
| atropine | Solution (eye drops) | 0.1% (sulfate) | |
| atropine | Solution (eye drops) | 0.5% (sulfate) | |
| atropine | Solution (eye drops) | 1% (sulfate) | |
| cyclopentolate | eye drops | 0.5 % | |
| homatropine | Solution (eye drops) | 2% | |
| oxymethazoline | Nasal drops | 0.5% x 10ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ergometrine | Injection | 0.2 mg/mL (maleate) in 1-mL ampoule | |
| magnesium sulfate | Injection | 500 mg/mL in 2-mL ampoule | |
| methylergometrine | Tablet | 200 mcg | |
| oxytocin | Injection | 10 IU in 1-mL ampoule | |
| oxytocin | Injection | 5 IU/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ritodrine | Injection | 10mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| hemodialysis solution | Parenteral formulation | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chlorpromazine | Injection | 25 mg (hydrochloride)/mL in 2-mL ampoule | |
| chlorpromazine | Tablet | 10 mg (hydrochloride) | |
| chlorpromazine | Tablet | 100 mg (hydrochloride) | |
| clozapine | Tablet | 100mg | |
| clozapine | Tablet | 25mg | |
| clozapine | Tablet | 50mg | |
| flupenthixol | Tablet | 1 mg | |
| fluphenazine | Injection | 25 mg (decanoate or enantate) in 1-mL ampoule | |
| haloperidol | Injection | 5 mg/mL in 1-mL ampoule | |
| quetiapine | Tablet | 100 mg | |
| quetiapine | Tablet | 50 mg | |
| resperidone | Injection | 25 mg/vial | |
| resperidone | Tablet | 2 mg | |
| thioridazine | Tablet | 100 mg | |
| thioridazine | Tablet | 25 mg | |
| trifluoperazine | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amitriptyline | Tablet | 25 mg | |
| amitriptyline | Tablet | 75 mg | |
| fluoxetine | Tablet | 20 mg | |
| imipramine | Tablet | 25 mg | |
| sertraline | Tablet | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carbamazepine | Tablet (scored) | 200 mg | |
| lithium carbonate | Tablet | 300 mg | |
| valproic acid (sodium valproate) | Tablet | 250 mg | |
| valproic acid (sodium valproate) | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| alprazolam | Tablet | 0.25 mg | |
| clonazepam | Tablet | 1 mg | |
| diazepam | Injection | 5 mg/mL | |
| diazepam | Tablet (scored) | 5 mg | |
| diphenhydramine | Injection | 25 mg | |
| diphenhydramine | Injection | 50 mg/mL | |
| diphenhydramine | Tablet | 25 mg | |
| diphenhydramine | Tablet | 50 mg | |
| lorazepam | Injection | 4 mg/ml | |
| lorazepam | Tablet | 1 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clomipramine | Capsule | 10 mg (hydrochloride) | |
| clomipramine | Capsule | 25 mg (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aminophylline | Injection | 25 mg/mL | |
| beclometasone | Inhalation (aerosol) | 250 micrograms (dipropionate) per dose | |
| beclometasone | Inhalation (aerosol) | 50 mcg (dipropionate) per dose (as CFC free forms) | |
| ipratropium bromide | Inhalation (aerosol) | 20 micrograms/metered dose | |
| montelukast | Tablet | 10 mg | |
| salbutamol | Inhalation (aerosol) | 100 mcg (as sulfate) per dose | |
| salbutamol | Oral liquid | 2 mg/5 mL | |
| salbutamol | respirator solution for use in nebulizers | 5 mg (as sulfate)/mL | |
| salbutamol | Tablet | 4 mg | |
| salmeterol | Inhalation (aerosol) | 25mcg/spray (6.5g) | |
| theophylline | Tablet | 100 mg | |
| theophylline | Tablet | 125 mg | |
| theophylline | Tablet | 250 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| caffeine citrate | Injection | 20 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| calcium | Tablet | 300 mg (carbonate/ lactate) | |
| calcium acetate | Injection | 100 mg/ml | |
| oral rehydration salts * (for glucose-electrolyte solution) | Solution | N/A | |
| potassium chloride | Powder for solution | N/A | |
| sodium bicarbonate | Injection | 8.4% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| glucose | Injectable solution | 10% isotonic | |
| glucose | Injectable solution | 5% dextrose | |
| glucose | Injectable solution | 50% (hypertonic) | |
| potassium chloride | Solution | 11.2% in 20-ml ampoule (equivalent to K+ 1.5 mmol/ml, Cl 1.5 mmol/ml) | |
| sodium chloride | Injectable solution | 0.9% isotonic (equivalent to Na+ 154 mmol/L, Cl- 154 mmol/L) | |
| sodium chloride | Injection | 17.7 % | |
| sodium hydrogen carbonate | Injectable solution | 1.4% isotonic (equivalent to Na+ 167 mmol/L, HCO3- 167 mmol/L) | |
| sodium lactate, compound | Injectable solution | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| water for injection | Injection | 2-10ml ampoules | |
| water for injection | Injection | 5 mL in ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| calcium gluconate | Injection | 100 mg/mL in 10-mL ampoule | |
| calcium gluconate | Tablet | 300 mg | |
| CALCIUM SALT | Powder | 40 mEq | |
| CALCIUM SALT | Powder | 60mEq | |
| hydroxocobalamin | Injection | 10 ml | |
| iodine | Iodized oil | 1 ml (480 mg iodine) in ampoule (oral or injectable) | |
| levocarnitina | Tablet | 330 mg | |
| levocarnitina | Tablet (chewable) | 1 g | |
| pyridoxine | Tablet | 50 mg | |
| retinol | Capsule | 200 000 IU (as palmitate) | |
| retinol | Oral oily solution | 100 000 IU (as palmitate)/ml in multidose dispenser | |
| retinol | Tablet (sugar-coated) | 10 000 IU (as palmitate) | |
| retinol | Water-miscible injection | 100 000 IU (as palmitate) in 2-ml ampoule | |
| riboflavin | Tablet | 5 mg | |
| thiamine | Injection | 100 mg/mL | |
| thiamine | Tablet | 50 mg (hydrochloride) |